サンプル依頼リスト カート
  • English
  • Korean
市場調査レポート
商品コード
1462061

HIV注射の世界市場の規模、シェア、動向分析：流通チャネル別、地域別展望と予測（2023年～2030年）

Global HIV Injection Market Size, Share & Trends Analysis Report By Distribution Channel (Hospital Pharmacy, Drugs Stores & Retail Pharmacies, and Others), By Regional Outlook and Forecast, 2023 - 2030
出版日: | 発行: KBV Research | ページ情報: 英文 143 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
HIV注射の世界市場の規模、シェア、動向分析：流通チャネル別、地域別展望と予測（2023年～2030年）
出版日: 2024年03月21日
発行: KBV Research
ページ情報: 英文 143 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のHIVの市場規模は、2030年までに28億米ドルに達し、予測期間中にCAGR17.6%で成長すると予測されています。

さらに、革新的な製剤は従来の経口薬に比べていくつかの利点があり、市場での採用と需要の増加を促進しています。注射療法は一般的に経口薬よりも投与頻度が少なくて済むため、複雑な投薬スケジュールを守るのが難しい患者にとって特に有益です。したがって、HIV/AIDS治療用の革新的な注射製剤の開発は、HIV注射の需要にプラスの影響を及ぼしています。

しかし、注射薬を含むHIV治療の高額な費用は、特に低所得国および中所得国において、HIV/AIDSとともに生きる多くの人々にとって、依然として治療へのアクセスの大きな障壁となっています。HIV治療の費用には、薬自体の価格だけでなく、定期的なモニタリング、臨床検査、医療提供者の訪問の費用も含まれる可能性があり、これらはすぐに患者にとって大きな経済的負担になる可能性があります。したがって、高額な費用は市場の拡大を妨げる可能性があります。

COVID-19パンデミックは市場に大きな影響を与え、サプライチェーンのさまざまな側面と患者の治療へのアクセスに影響を及ぼしました。原材料不足と製造の遅れは世界のサプライチェーンの混乱に続き、注射剤を含むHIV治療薬に影響を与えました。これらの混乱は一部の地域での入手可能性に影響を与え、患者の治療中断につながる可能性がありました。このように、パンデミックは市場に悪影響を及ぼしました。

目次

第1章 市場範囲と調査手法

  • 市場の定義
  • 目的
  • 市場範囲
  • セグメンテーション
  • 調査手法

第2章 市場要覧

  • 主なハイライト

第3章 市場概要

  • イントロダクション
    • 概要
      • 市場構成とシナリオ
  • 市場に影響を与える主な要因
    • 市場促進要因
    • 市場機会
    • 市場抑制要因
    • 市場の課題
  • ポーターのファイブフォース分析

第4章 世界のHIV注射市場：流通チャネル別

  • 世界の院内薬局市場：地域別
  • 世界のドラッグストア・小売薬局市場：地域別
  • 世界のその他の市場：地域別

第5章 世界のHIV注射市場：地域別

  • 北米
    • 北米のHIV注射市場：国別
      • 米国
      • カナダ
      • メキシコ
      • その他北米
  • 欧州
    • 欧州のHIV注射市場：国別
      • ドイツ
      • 英国
      • フランス
      • ロシア
      • スペイン
      • イタリア
      • その他欧州
  • アジア太平洋
    • アジア太平洋のHIV注射市場：国別
      • 中国
      • 日本
      • インド
      • 韓国
      • シンガポール
      • マレーシア
      • その他アジア太平洋
  • ラテンアメリカ・中東・アフリカ
    • ラテンアメリカ・中東・アフリカのHIV注射市場：国別
      • ブラジル
      • アルゼンチン
      • アラブ首長国連邦
      • サウジアラビア
      • 南アフリカ
      • ナイジェリア
      • その他ラテンアメリカ・中東・アフリカ

第6章 企業プロファイル

  • GlaxoSmithKline PLC（GSK）
  • Gilead Sciences, Inc
  • ImmunityBio, Inc
  • F Hoffmann-La Roche Ltd.
  • Theratechnologies Inc
  • Viriom, Inc
  • AbbVie, Inc
  • Brii Biosciences Limited
  • Shionogi & Co, Ltd.
  • Boehringer Ingelheim International GmbH

第7章 HIV注射市場の成功必須条件

図表

LIST OF TABLES

  • TABLE 1Global HIV Injection Market, 2019 - 2022, USD Million
  • TABLE 2Global HIV Injection Market, 2023 - 2030, USD Million
  • TABLE 3Global HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 4Global HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 5Global Hospital Pharmacy Market by Region, 2019 - 2022, USD Million
  • TABLE 6Global Hospital Pharmacy Market by Region, 2023 - 2030, USD Million
  • TABLE 7Global Drugs Stores & Retail Pharmacies Market by Region, 2019 - 2022, USD Million
  • TABLE 8Global Drugs Stores & Retail Pharmacies Market by Region, 2023 - 2030, USD Million
  • TABLE 9Global Others Market by Region, 2019 - 2022, USD Million
  • TABLE 10Global Others Market by Region, 2023 - 2030, USD Million
  • TABLE 11Global HIV Injection Market by Region, 2019 - 2022, USD Million
  • TABLE 12Global HIV Injection Market by Region, 2023 - 2030, USD Million
  • TABLE 13North America HIV Injection Market, 2019 - 2022, USD Million
  • TABLE 14North America HIV Injection Market, 2023 - 2030, USD Million
  • TABLE 15North America HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 16North America HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 17North America Hospital Pharmacy Market by Country, 2019 - 2022, USD Million
  • TABLE 18North America Hospital Pharmacy Market by Country, 2023 - 2030, USD Million
  • TABLE 19North America Drugs Stores & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
  • TABLE 20North America Drugs Stores & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
  • TABLE 21North America Others Market by Country, 2019 - 2022, USD Million
  • TABLE 22North America Others Market by Country, 2023 - 2030, USD Million
  • TABLE 23North America HIV Injection Market by Country, 2019 - 2022, USD Million
  • TABLE 24North America HIV Injection Market by Country, 2023 - 2030, USD Million
  • TABLE 25US HIV Injection Market, 2019 - 2022, USD Million
  • TABLE 26US HIV Injection Market, 2023 - 2030, USD Million
  • TABLE 27US HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 28US HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 29Canada HIV Injection Market, 2019 - 2022, USD Million
  • TABLE 30Canada HIV Injection Market, 2023 - 2030, USD Million
  • TABLE 31Canada HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 32Canada HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 33Mexico HIV Injection Market, 2019 - 2022, USD Million
  • TABLE 34Mexico HIV Injection Market, 2023 - 2030, USD Million
  • TABLE 35Mexico HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 36Mexico HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 37Rest of North America HIV Injection Market, 2019 - 2022, USD Million
  • TABLE 38Rest of North America HIV Injection Market, 2023 - 2030, USD Million
  • TABLE 39Rest of North America HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 40Rest of North America HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 41Europe HIV Injection Market, 2019 - 2022, USD Million
  • TABLE 42Europe HIV Injection Market, 2023 - 2030, USD Million
  • TABLE 43Europe HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 44Europe HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 45Europe Hospital Pharmacy Market by Country, 2019 - 2022, USD Million
  • TABLE 46Europe Hospital Pharmacy Market by Country, 2023 - 2030, USD Million
  • TABLE 47Europe Drugs Stores & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
  • TABLE 48Europe Drugs Stores & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
  • TABLE 49Europe Others Market by Country, 2019 - 2022, USD Million
  • TABLE 50Europe Others Market by Country, 2023 - 2030, USD Million
  • TABLE 51Europe HIV Injection Market by Country, 2019 - 2022, USD Million
  • TABLE 52Europe HIV Injection Market by Country, 2023 - 2030, USD Million
  • TABLE 53Germany HIV Injection Market, 2019 - 2022, USD Million
  • TABLE 54Germany HIV Injection Market, 2023 - 2030, USD Million
  • TABLE 55Germany HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 56Germany HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 57UK HIV Injection Market, 2019 - 2022, USD Million
  • TABLE 58UK HIV Injection Market, 2023 - 2030, USD Million
  • TABLE 59UK HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 60UK HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 61France HIV Injection Market, 2019 - 2022, USD Million
  • TABLE 62France HIV Injection Market, 2023 - 2030, USD Million
  • TABLE 63France HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 64France HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 65Russia HIV Injection Market, 2019 - 2022, USD Million
  • TABLE 66Russia HIV Injection Market, 2023 - 2030, USD Million
  • TABLE 67Russia HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 68Russia HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 69Spain HIV Injection Market, 2019 - 2022, USD Million
  • TABLE 70Spain HIV Injection Market, 2023 - 2030, USD Million
  • TABLE 71Spain HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 72Spain HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 73Italy HIV Injection Market, 2019 - 2022, USD Million
  • TABLE 74Italy HIV Injection Market, 2023 - 2030, USD Million
  • TABLE 75Italy HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 76Italy HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 77Rest of Europe HIV Injection Market, 2019 - 2022, USD Million
  • TABLE 78Rest of Europe HIV Injection Market, 2023 - 2030, USD Million
  • TABLE 79Rest of Europe HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 80Rest of Europe HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 81Asia Pacific HIV Injection Market, 2019 - 2022, USD Million
  • TABLE 82Asia Pacific HIV Injection Market, 2023 - 2030, USD Million
  • TABLE 83Asia Pacific HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 84Asia Pacific HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 85Asia Pacific Hospital Pharmacy Market by Country, 2019 - 2022, USD Million
  • TABLE 86Asia Pacific Hospital Pharmacy Market by Country, 2023 - 2030, USD Million
  • TABLE 87Asia Pacific Drugs Stores & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
  • TABLE 88Asia Pacific Drugs Stores & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
  • TABLE 89Asia Pacific Others Market by Country, 2019 - 2022, USD Million
  • TABLE 90Asia Pacific Others Market by Country, 2023 - 2030, USD Million
  • TABLE 91Asia Pacific HIV Injection Market by Country, 2019 - 2022, USD Million
  • TABLE 92Asia Pacific HIV Injection Market by Country, 2023 - 2030, USD Million
  • TABLE 93China HIV Injection Market, 2019 - 2022, USD Million
  • TABLE 94China HIV Injection Market, 2023 - 2030, USD Million
  • TABLE 95China HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 96China HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 97Japan HIV Injection Market, 2019 - 2022, USD Million
  • TABLE 98Japan HIV Injection Market, 2023 - 2030, USD Million
  • TABLE 99Japan HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 100Japan HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 101India HIV Injection Market, 2019 - 2022, USD Million
  • TABLE 102India HIV Injection Market, 2023 - 2030, USD Million
  • TABLE 103India HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 104India HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 105South Korea HIV Injection Market, 2019 - 2022, USD Million
  • TABLE 106South Korea HIV Injection Market, 2023 - 2030, USD Million
  • TABLE 107South Korea HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 108South Korea HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 109Singapore HIV Injection Market, 2019 - 2022, USD Million
  • TABLE 110Singapore HIV Injection Market, 2023 - 2030, USD Million
  • TABLE 111Singapore HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 112Singapore HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 113Malaysia HIV Injection Market, 2019 - 2022, USD Million
  • TABLE 114Malaysia HIV Injection Market, 2023 - 2030, USD Million
  • TABLE 115Malaysia HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 116Malaysia HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 117Rest of Asia Pacific HIV Injection Market, 2019 - 2022, USD Million
  • TABLE 118Rest of Asia Pacific HIV Injection Market, 2023 - 2030, USD Million
  • TABLE 119Rest of Asia Pacific HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 120Rest of Asia Pacific HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 121LAMEA HIV Injection Market, 2019 - 2022, USD Million
  • TABLE 122LAMEA HIV Injection Market, 2023 - 2030, USD Million
  • TABLE 123LAMEA HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 124LAMEA HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 125LAMEA Hospital Pharmacy Market by Country, 2019 - 2022, USD Million
  • TABLE 126LAMEA Hospital Pharmacy Market by Country, 2023 - 2030, USD Million
  • TABLE 127LAMEA Drugs Stores & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
  • TABLE 128LAMEA Drugs Stores & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
  • TABLE 129LAMEA Others Market by Country, 2019 - 2022, USD Million
  • TABLE 130LAMEA Others Market by Country, 2023 - 2030, USD Million
  • TABLE 131LAMEA HIV Injection Market by Country, 2019 - 2022, USD Million
  • TABLE 132LAMEA HIV Injection Market by Country, 2023 - 2030, USD Million
  • TABLE 133Brazil HIV Injection Market, 2019 - 2022, USD Million
  • TABLE 134Brazil HIV Injection Market, 2023 - 2030, USD Million
  • TABLE 135Brazil HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 136Brazil HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 137Argentina HIV Injection Market, 2019 - 2022, USD Million
  • TABLE 138Argentina HIV Injection Market, 2023 - 2030, USD Million
  • TABLE 139Argentina HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 140Argentina HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 141UAE HIV Injection Market, 2019 - 2022, USD Million
  • TABLE 142UAE HIV Injection Market, 2023 - 2030, USD Million
  • TABLE 143UAE HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 144UAE HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 145Saudi Arabia HIV Injection Market, 2019 - 2022, USD Million
  • TABLE 146Saudi Arabia HIV Injection Market, 2023 - 2030, USD Million
  • TABLE 147Saudi Arabia HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 148Saudi Arabia HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 149South Africa HIV Injection Market, 2019 - 2022, USD Million
  • TABLE 150South Africa HIV Injection Market, 2023 - 2030, USD Million
  • TABLE 151South Africa HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 152South Africa HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 153Nigeria HIV Injection Market, 2019 - 2022, USD Million
  • TABLE 154Nigeria HIV Injection Market, 2023 - 2030, USD Million
  • TABLE 155Nigeria HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 156Nigeria HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 157Rest of LAMEA HIV Injection Market, 2019 - 2022, USD Million
  • TABLE 158Rest of LAMEA HIV Injection Market, 2023 - 2030, USD Million
  • TABLE 159Rest of LAMEA HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 160Rest of LAMEA HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 161Key Information - GlaxoSmithKline PLC
  • TABLE 162Key Information - Gilead Sciences, Inc.
  • TABLE 163Key Information - ImmunityBio, Inc.
  • TABLE 164Key Information - F. Hoffmann-La Roche Ltd.
  • TABLE 165Key Information - Theratechnologies Inc.
  • TABLE 166Key Information - Viriom, Inc.
  • TABLE 167Key information - AbbVie, Inc.
  • TABLE 168Key Information - Brii Biosciences Limited
  • TABLE 169Key Information - Shionogi & Co., Ltd.
  • TABLE 170Key Information - Boehringer Ingelheim International GmbH
目次

The Global HIV Injection Market size is expected to reach $2.8 billion by 2030, rising at a market growth of 17.6% CAGR during the forecast period.

North America, particularly the United States, has a relatively high prevalence of HIV compared to other regions. Therefore, the North America segment captured $368.07 million revenue in the market in 2022. This high prevalence creates a substantial demand for HIV medications, including injectable therapies. North America is at the forefront of HIV research and treatment, leading to the development of new and innovative HIV medications, including injectable therapies.

The escalating prevalence of HIV/AIDS necessitates the development of more efficacious treatment modalities to alleviate symptoms and sustain life. This increased demand has driven pharmaceutical companies and researchers to develop new and innovative HIV injections to meet the growing needs of patients. Thus, the increasing prevalence of HIV is supporting the growth of the market.

Additionally, the innovative formulations offer several advantages over traditional oral medications, driving their adoption and increasing demand in the market. Injectable therapies typically require less frequent dosing than oral medications, which can be particularly beneficial for patients with difficulty adhering to complex medication schedules. Therefore, the development of innovative injectable formulations for the treatment of HIV/AIDS has had a positive impact on the demand for HIV injections.

However, the high cost of HIV treatment, including injectable medications, remains a significant barrier to access for many people living with HIV/AIDS, particularly in low- and middle-income countries. The cost of HIV treatment can include not only the price of the medication itself but also the cost of regular monitoring, laboratory tests, and healthcare provider visits, which can quickly add up to a substantial financial burden for patients. Hence, the high cost might hamper the expansion of the market.

The COVID-19 pandemic had a significant impact on the market, affecting various aspects of the supply chain and patient access to treatment. Raw material shortages and manufacturing delays followed disruptions in the global supply chain, which affected HIV medications, including injectable therapies. These disruptions impacted their availability in some regions, potentially leading to treatment interruptions for patients. Thus, the pandemic affected the market negatively

By Distribution Channel Analysis

Based on distribution channel, the market is divided into hospital pharmacy, drug stores & retail pharmacies, and others. The hospital pharmacy segment procured 46.2% revenue share in the market in 2022. Hospitals, clinics, and other healthcare facilities are major distribution points for HIV injections. They receive medications from pharmaceutical companies or wholesalers and distribute them to patients as part of their treatment regimens.

By Regional Analysis

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The LAMEA segment witnessed 5.3% revenue share in the market in 2022. The LAMEA region has a relatively high prevalence of HIV, with certain countries in sub-Saharan Africa experiencing particularly high rates of infection. Governments in the LAMEA region have implemented various initiatives to address the HIV/AIDS epidemic, including funding for HIV/AIDS programs and improving access to treatment.

List of Key Companies Profiled

  • GlaxoSmithKline PLC (GSK)
  • Gilead Sciences, Inc.
  • ImmunityBio, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Theratechnologies Inc.
  • Viriom, Inc.
  • AbbVie, Inc.
  • Brii Biosciences Limited
  • Shionogi & Co., Ltd.
  • Boehringer Ingelheim International GmbH

Global HIV Injection Market Report Segmentation

By Distribution Channel

  • Hospital Pharmacy
  • Drugs Stores & Retail Pharmacies
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Table of Contents

Chapter 1.Market Scope & Methodology

  • 1.1Market Definition
  • 1.2Objectives
  • 1.3Market Scope
  • 1.4Segmentation
    • 1.4.1Global HIV Injection Market, by Distribution Channel
    • 1.4.2Global HIV Injection Market, by Geography
  • 1.5Methodology for the research

Chapter 2.Market at a Glance

  • 2.1Key Highlights

Chapter 3.Market Overview

  • 3.1Introduction
    • 3.1.1Overview
      • 3.1.1.1Market Composition and Scenario
  • 3.2Key Factors Impacting the Market
    • 3.2.1Market Drivers
    • 3.2.2Market Opportunities
    • 3.2.3Market Restraints
    • 3.2.4Market Challenges
  • 3.3Porter's Five Forces Analysis

Chapter 4.Global HIV Injection Market by Distribution Channel

  • 4.1Global Hospital Pharmacy Market by Region
  • 4.2Global Drugs Stores & Retail Pharmacies Market by Region
  • 4.3Global Others Market by Region

Chapter 5.Global HIV Injection Market by Region

  • 5.1North America HIV Injection Market
    • 5.1.1North America HIV Injection Market by Distribution Channel
      • 5.1.1.1North America Hospital Pharmacy Market by Country
      • 5.1.1.2North America Drugs Stores & Retail Pharmacies Market by Country
      • 5.1.1.3North America Others Market by Country
    • 5.1.2North America HIV Injection Market by Country
      • 5.1.2.1US HIV Injection Market
        • 5.1.2.1.1US HIV Injection Market by Distribution Channel
      • 5.1.2.2Canada HIV Injection Market
        • 5.1.2.2.1Canada HIV Injection Market by Distribution Channel
      • 5.1.2.3Mexico HIV Injection Market
        • 5.1.2.3.1Mexico HIV Injection Market by Distribution Channel
      • 5.1.2.4Rest of North America HIV Injection Market
        • 5.1.2.4.1Rest of North America HIV Injection Market by Distribution Channel
  • 5.2Europe HIV Injection Market
    • 5.2.1Europe HIV Injection Market by Distribution Channel
      • 5.2.1.1Europe Hospital Pharmacy Market by Country
      • 5.2.1.2Europe Drugs Stores & Retail Pharmacies Market by Country
      • 5.2.1.3Europe Others Market by Country
    • 5.2.2Europe HIV Injection Market by Country
      • 5.2.2.1Germany HIV Injection Market
        • 5.2.2.1.1Germany HIV Injection Market by Distribution Channel
      • 5.2.2.2UK HIV Injection Market
        • 5.2.2.2.1UK HIV Injection Market by Distribution Channel
      • 5.2.2.3France HIV Injection Market
        • 5.2.2.3.1France HIV Injection Market by Distribution Channel
      • 5.2.2.4Russia HIV Injection Market
        • 5.2.2.4.1Russia HIV Injection Market by Distribution Channel
      • 5.2.2.5Spain HIV Injection Market
        • 5.2.2.5.1Spain HIV Injection Market by Distribution Channel
      • 5.2.2.6Italy HIV Injection Market
        • 5.2.2.6.1Italy HIV Injection Market by Distribution Channel
      • 5.2.2.7Rest of Europe HIV Injection Market
        • 5.2.2.7.1Rest of Europe HIV Injection Market by Distribution Channel
  • 5.3Asia Pacific HIV Injection Market
    • 5.3.1Asia Pacific HIV Injection Market by Distribution Channel
      • 5.3.1.1Asia Pacific Hospital Pharmacy Market by Country
      • 5.3.1.2Asia Pacific Drugs Stores & Retail Pharmacies Market by Country
      • 5.3.1.3Asia Pacific Others Market by Country
    • 5.3.2Asia Pacific HIV Injection Market by Country
      • 5.3.2.1China HIV Injection Market
        • 5.3.2.1.1China HIV Injection Market by Distribution Channel
      • 5.3.2.2Japan HIV Injection Market
        • 5.3.2.2.1Japan HIV Injection Market by Distribution Channel
      • 5.3.2.3India HIV Injection Market
        • 5.3.2.3.1India HIV Injection Market by Distribution Channel
      • 5.3.2.4South Korea HIV Injection Market
        • 5.3.2.4.1South Korea HIV Injection Market by Distribution Channel
      • 5.3.2.5Singapore HIV Injection Market
        • 5.3.2.5.1Singapore HIV Injection Market by Distribution Channel
      • 5.3.2.6Malaysia HIV Injection Market
        • 5.3.2.6.1Malaysia HIV Injection Market by Distribution Channel
      • 5.3.2.7Rest of Asia Pacific HIV Injection Market
        • 5.3.2.7.1Rest of Asia Pacific HIV Injection Market by Distribution Channel
  • 5.4LAMEA HIV Injection Market
    • 5.4.1LAMEA HIV Injection Market by Distribution Channel
      • 5.4.1.1LAMEA Hospital Pharmacy Market by Country
      • 5.4.1.2LAMEA Drugs Stores & Retail Pharmacies Market by Country
      • 5.4.1.3LAMEA Others Market by Country
    • 5.4.2LAMEA HIV Injection Market by Country
      • 5.4.2.1Brazil HIV Injection Market
        • 5.4.2.1.1Brazil HIV Injection Market by Distribution Channel
      • 5.4.2.2Argentina HIV Injection Market
        • 5.4.2.2.1Argentina HIV Injection Market by Distribution Channel
      • 5.4.2.3UAE HIV Injection Market
        • 5.4.2.3.1UAE HIV Injection Market by Distribution Channel
      • 5.4.2.4Saudi Arabia HIV Injection Market
        • 5.4.2.4.1Saudi Arabia HIV Injection Market by Distribution Channel
      • 5.4.2.5South Africa HIV Injection Market
        • 5.4.2.5.1South Africa HIV Injection Market by Distribution Channel
      • 5.4.2.6Nigeria HIV Injection Market
        • 5.4.2.6.1Nigeria HIV Injection Market by Distribution Channel
      • 5.4.2.7Rest of LAMEA HIV Injection Market
        • 5.4.2.7.1Rest of LAMEA HIV Injection Market by Distribution Channel

Chapter 6.Company Profiles

  • 6.1GlaxoSmithKline PLC (GSK)
    • 6.1.1Company Overview
    • 6.1.2Financial Analysis
    • 6.1.3Regional Analysis
    • 6.1.4Research & Development Expense
    • 6.1.5SWOT Analysis
  • 6.1Gilead Sciences, Inc.
    • 6.1.1Company overview
    • 6.1.2Financial Analysis
    • 6.1.3Research & Development Expenses
    • 6.1.4SWOT Analysis
  • 6.2ImmunityBio, Inc.
    • 6.2.1Company Overview
    • 6.2.2Financial Analysis
    • 6.2.3Regional Analysis
    • 6.2.4Research & Development Expenses
    • 6.2.5SWOT Analysis
  • 6.3F. Hoffmann-La Roche Ltd.
    • 6.3.1Company Overview
    • 6.3.2Financial Analysis
    • 6.3.3Segmental and Regional Analysis
    • 6.3.4Research & Development Expense
    • 6.3.5SWOT Analysis
  • 6.4Theratechnologies Inc.
    • 6.4.1Company Overview
    • 6.4.2Financial Analysis
    • 6.4.3Research & Development Expenses
    • 6.4.4SWOT Analysis
  • 6.5Viriom, Inc.
    • 6.5.1Company Overview
    • 6.5.2SWOT Analysis
  • 6.6AbbVie, Inc.
    • 6.6.1Company Overview
    • 6.6.2Financial Analysis
    • 6.6.3Regional Analysis
    • 6.6.4Research & Development Expense
    • 6.6.5SWOT Analysis
  • 6.7Brii Biosciences Limited
    • 6.7.1Company Overview
    • 6.7.2Financial Analysis
    • 6.7.3Research & Development Expenses
    • 6.7.4SWOT Analysis
  • 6.8Shionogi & Co., Ltd.
    • 6.8.1Company Overview
    • 6.8.2Financial Analysis
    • 6.8.3Research & Development Expenses
    • 6.8.4SWOT Analysis
  • 6.9Boehringer Ingelheim International GmbH
    • 6.9.1Company Overview
    • 6.9.2Financial Analysis
    • 6.9.3Regional & Segmental Analysis
    • 6.9.4Research & Development Expenses
    • 6.9.5SWOT Analysis

Chapter 7.Winning Imperatives of HIV Injection Market